At Boston Medical Center (BMC), we are dedicated to the highest quality and safest care for our patients. BMC adheres to Stroke Performance and Outcome Measures put forth by the American Heart Association (AHA). Below are our 2022 Performance Measure scores, through Q3, compared with all Massachusetts and U.S. hospitals in the AHA stroke registry. Our goal is 95% or better with each measure.
| 2022 Performance and Outcome Measures (through Q3) | Boston Medical Center | All CSC hospitals |
|---|---|---|
Venous thrombus embolism (VTE): Stroke patients who received blood clot prevention by the end of day 2 | 98% | 96% |
| Ischemic stroke patients prescribed medication to prevent blood clots and/or medication to prevent platelets clumping and growing to prevent stroke at discharge | 100% | 99% |
| Stroke patients with atrial fibrillation/flutter who are prescribed a blood thinner (anticoagulation) at hospital discharge | 100%
| 98%
|
| Stroke patients who arrive at this hospital within two hours of time last known well and for whom IV alteplase (a clot-busting drug) was initiated within three hours of time last known well | 100% | 93% |
| Ischemic stroke patients prescribed medication to prevent blood clots and/or medication to prevent platelets clumping and growing to prevent stroke by the second day they are in the hospital | 97%
| 97%
|
| Stroke patients who are prescribed cholesterol (statin) medication at hospital discharge | 100% | 97% |
| Stroke patients or their caregivers who were given stroke education materials during hospital stay | 100% | 95% |
| Stroke patients who were assessed for rehabilitation services before discharge | 99% | 99% |
Thrombolysis in cerebral infarction score (TICI 2B) post treatment reperfusion grade Thrombectomy is a treatment to eliminate an acute blood clot in the brain | 85% | 85% |
Arrival to skin puncture for thrombectomy The time it takes to start a thrombectomy procedure from when a patient arrives in the hospital | 53 minutes | 72 minutes |